Avec l'@APM_france nous nous réjouissons de cette nouvelle avancée législative qui illustre la volonté de la France de favoriser les avancées médicales dans le domaine du microbiote ow.ly/1nuh50PEfLh

[#media] - Members from APM, Seventure Partners and MaaT Pharma are featured in the latest article on the transformative potential of the microbiome in cancer care in Inside Precision Medicine. 🦠 lnkd.in/esmQDMhs #Microbiome #CancerInnovation #Research #Cancer #APMProud

[ON RECRUTE] Nous recrutons pour notre site de Saint-Herblain, près de Nantes ! Retrouvez toutes nos offres sur notre espace carrière : biofortis.fr/job-offers/ Rejoignez l’aventure Biofortis ! #recrutement #iciçarecrute #jobs #emploi #talents #recrute #nantes

Retrouvez notre expert Joel Dore dans cette interview menée par #Digesteam Joel parle du #microbiote, élément clé de notre #santé et mentionne Le French Gut - Le microbiote français pour accélérer la #science du #microbiote, source d'#innovation en #médecine @inrae_france youtu.be/ipJnztNfWYc

“Mauvais sang”- Livre de Elisabeth Schemla et de Mohamad Mohty - Précommande #fnac fnac.com/a18289199/Elis… AF3M Asso SFGM-TC Académie de médecine de France Sorbonne Université Assistance Publique – Hôpitaux de Paris (AP-HP) Faculté de Santé de Sorbonne Université Faculté des Lettres Sorbonne Université Hôpital Saint-Antoine AP-HP The EBMT IACH COMy Hématologie FrequenceMedicale

📄 [Press Release] – MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013. 👉lnkd.in/eKuYSCyr

#NEWS: We’re pleased to announce our collaboration with PharmaBiome. This R&D agreement builds on PharmaBiome’s technology to develop microbiome-based therapeutics, helping patients with gastroenterological diseases live better lives. bit.ly/3NndDYN

💣Introduction of VOWST by Seres Therapeutics in June was pivotal for the #microbiome industry. It goes beyond 💥commercial own success, serving as an indicator of 👨‍⚕️patient care approaches. This reflects the industry's progression for patient benefit @APM_france tinyurl.com/y9je8db2

The latest articles published in “Clinical Hematology International”, the official peer-reviewed full open access journal of IACH (no submission fees or page charges). chi.scholasticahq.com/articles

🎗️ On #WorldCancerDay, we reaffirm our commitment to patients and our focus on bringing gut microbiome innovations to transform cancer treatment. Gratitude to healthcare champions. Together, let's keep on innovating for the patients! #GutMicrobiome #Microbiota #CancerAwareness 🦠

[#ACTU] 📣 L’Alliance Promotion Microbiote devient l’European Microbiome Innovation for Health #EMIH : une étape majeure pour structurer la filière d’excellence européenne du microbiote. 🌍 🖥 Lire le CP : frenchmicrobiome.org/fr/lalliance-p… #Innovations #Microbiote #Europe

[#NEWS] 📣 The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health hashtag#EMIH: a major step towards structuring the European microbiome excellence sector. 🌍 🖥 Read the PR: frenchmicrobiome.org/european-micro… #Innovations #Microbiome #Europe

[#Event] - We are proud to announce that EMIH’s members will be presenting and exhibiting at The The Microbiome Times Partnering Forum! This exciting event will bring together leading innovators and experts in the microbiome industry to share their latest advancements and insights.

New #Member- We are thrilled to welcome Laboratoire PiLeJe as a new member of EMIH! 👏 Together, we will drive impactful change and unlock the potential of the microbiome in healthcare. Please join us in welcoming PiLeJe to the EMIH community! 🙌 #MicrobiomeInnovation

We don't know yet what is a healthy gut microbiome New studies characterize healthy gut microbiome trajectories in children and adults and link them to health outcomes: loom.ly/IWsc5hI

📰 MaaT Pharma in CancerNetwork® ! We’re thrilled to see our latest achievement covered in CancerNetwork® with Roman Fabbricatore highlighting our phase 3 ARES results, confirming MaaT013’s positive benefit/risk profile and its potential as a third-line treatment for GI-aGvHD.

#AutismAwarenessDay Using AI and machine learning, researchers have identified 26 bacterial taxa in the #gut #microbiota that can distinguish children with an autism spectrum disorder (ASD) from those without Could AI revolutionize the diagnosis and management of ASD? Explore👇

Research University of Utah Health highlights role of #gut #microbiome & #diabetes risk. Researchers have found that changes in the microbiome can impact insulin-producing cells, leading to long-term changes and increased risk for type 1 diabetes ow.ly/zAtS50VsYCB Managed Healthcare

#PressRelease - 🌍 500+ experts met in Brussels for the 2025 Microbiome Times Forum to discuss a dedicated EU framework on microbiome innovation. 📢 Read the press release: europeanmicrobiome.org/the-microbiome… #Microbiome #SoHO #EMA #EMIH #MTIG .The Microbiome Times